Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.

Nature cell biology | Feb 22, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11175744

The inhibitors of apoptosis (IAPs) suppress apoptosis through the inhibition of the caspase cascade and thus are key proteins in the control of cell death. Here we have isolated the protein XIAP-associated factor 1 (XAF1) on the basis of its ability to bind XIAP, a member of the IAP family. XIAP suppresses caspase activation and cell death in vitro, and XAF1 antagonizes these XIAP activities. Expression of XAF1 triggers a redistribution of XIAP from the cytosol to the nucleus. XAF1 is ubiquitously expressed in normal tissues, but is present at low or undetectable levels in many different cancer cell lines. Loss of control over apoptotic signalling is now recognized as a critical event in the development of cancer. Our results indicate that XAF1 may be important in mediating the apoptosis resistance of cancer cells.

Pubmed ID: 11175744 RIS Download

Mesh terms: Adenoviridae | Animals | Antineoplastic Agents, Phytogenic | Apoptosis | Blotting, Northern | Blotting, Western | Caspase Inhibitors | Caspases | Cell Survival | Culture Media, Serum-Free | Enzyme Inhibitors | Etoposide | Genes, Reporter | Humans | Intracellular Signaling Peptides and Proteins | Molecular Sequence Data | Neoplasm Proteins | Plasmids | Proteins | Recombinant Fusion Proteins | Tumor Cells, Cultured | Two-Hybrid System Techniques | X-Linked Inhibitor of Apoptosis Protein | Zinc Fingers

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.